300406 九强生物
已收盘 05-29 15:00:00
资讯
新帖
简况
九强生物(300406)披露“九强转债”恢复转股提示性公告,5月28日股价上涨0.16%
证券之星 · 05-28 22:43
九强生物(300406)披露“九强转债”恢复转股提示性公告,5月28日股价上涨0.16%
九强生物(300406)披露可转债转股价格调整公告,5月27日股价下跌1.88%
证券之星 · 05-27
九强生物(300406)披露可转债转股价格调整公告,5月27日股价下跌1.88%
九强生物:公司2025年年度权益分派股权登记日为
证券之星 · 05-25
九强生物:公司2025年年度权益分派股权登记日为
股市必读:九强生物(300406)5月20日董秘有最新回复
证券之星 · 05-21
股市必读:九强生物(300406)5月20日董秘有最新回复
九强生物(300406)披露权益分派期间“九强转债”暂停转股公告,5月20日股价下跌1.08%
证券之星 · 05-20
九强生物(300406)披露权益分派期间“九强转债”暂停转股公告,5月20日股价下跌1.08%
九强生物(300406)披露2025年年度股东会决议公告,5月19日股价上涨0.46%
证券之星 · 05-19
九强生物(300406)披露2025年年度股东会决议公告,5月19日股价上涨0.46%
股市必读:九强生物(300406)5月15日披露最新机构调研信息
证券之星 · 05-18
股市必读:九强生物(300406)5月15日披露最新机构调研信息
九强生物最新公告:取得三项医疗器械注册证书
证券之星 · 05-06
九强生物最新公告:取得三项医疗器械注册证书
股市必读:4月30日九强生物现874.37万元大宗交易
证券之星 · 05-06
股市必读:4月30日九强生物现874.37万元大宗交易
股市必读:4月29日九强生物现1010.21万元大宗交易
证券之星 · 04-30
股市必读:4月29日九强生物现1010.21万元大宗交易
4月28日九强生物发生1笔大宗交易 成交金额1600.3万元
中金财经 · 04-28
4月28日九强生物发生1笔大宗交易 成交金额1600.3万元
九强生物(300406)2026年一季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 04-28
九强生物(300406)2026年一季报简析:营收净利润同比双双增长,盈利能力上升
九强生物(300406)3月31日股东户数2.12万户,较上期增加18.01%
证券之星 · 04-26
九强生物(300406)3月31日股东户数2.12万户,较上期增加18.01%
图解九强生物年报:第四季度单季净利润同比下降150.08%
证券之星 · 04-26
图解九强生物年报:第四季度单季净利润同比下降150.08%
4月24日九强生物现500.76万元大宗交易
证券之星 · 04-24
4月24日九强生物现500.76万元大宗交易
九强生物(300406.SZ)子公司取得一项医疗器械注册证
智通财经 · 04-13
九强生物(300406.SZ)子公司取得一项医疗器械注册证
九强生物(300406)披露获得2项发明专利证书公告,4月3日股价下跌3.05%
证券之星 · 04-03
九强生物(300406)披露获得2项发明专利证书公告,4月3日股价下跌3.05%
九强生物(300406.SZ)子公司取得多项医疗器械注册证
智通财经网 · 03-31
九强生物(300406.SZ)子公司取得多项医疗器械注册证
九强生物(300406)披露获得2项发明专利证书公告,3月26日股价下跌1.62%
证券之星 · 03-26
九强生物(300406)披露获得2项发明专利证书公告,3月26日股价下跌1.62%
3月20日九强生物创60日新低,招商医药健康产业股票基金重仓该股
证券之星 · 03-20
3月20日九强生物创60日新低,招商医药健康产业股票基金重仓该股
加载更多
公司概况
公司名称:
北京九强生物技术股份有限公司
所属行业:
医药制造业
上市日期:
2014-10-30
主营业务:
北京九强生物技术股份有限公司的主营业务是体外诊断试剂及体外诊断仪器的生产及销售。公司的主要产品是病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统、液体活检系统。2025年1月14日,公司荣获“军事科学技术进步一等奖”,2025年12月6日,公司凭借高质量的信息披露水平、高效的沟通方式、优异的公共关系管理和投资者关系管理能力,荣获“金信披奖”。
发行价格:
14.32
{"stockData":{"symbol":"300406","market":"SZ","secType":"STK","nameCN":"九强生物","latestPrice":11.75,"timestamp":1780038231000,"preClose":11.83,"halted":0,"volume":5855777,"delay":0,"changeRate":-0.0068,"floatShares":424000000,"shares":586000000,"eps":0.362,"marketStatus":"已收盘","change":-0.08,"latestTime":"05-29 15:00:00","open":11.77,"high":11.85,"low":11.51,"amount":68168500,"amplitude":0.0287,"askPrice":11.76,"askSize":155,"bidPrice":11.75,"bidSize":202,"shortable":0,"etf":0,"ttmEps":0.362,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780277400000},"marketStatusCode":5,"adr":0,"adjPreClose":11.83,"symbolType":"stock","openAndCloseTimeList":[[1780018200000,1780025400000],[1780030800000,1780038000000]],"highLimit":13.01,"lowLimit":10.65,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":586308628,"isCdr":false,"pbRate":1.96,"roa":"--","peRate":32.458564,"roe":"2.74%","epsLYR":0.32,"committee":-0.25661,"marketValue":6889000000,"turnoverRate":0.0138,"status":1,"floatMarketCap":4986000000},"requestUrl":"/m/hq/s/300406","defaultTab":"news","newsList":[{"id":"2638943736","title":"九强生物(300406)披露“九强转债”恢复转股提示性公告,5月28日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638943736","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638943736?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:43","pubTimestamp":1779979393,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘,九强生物报收于12.53元,较前一交易日上涨0.16%,最新总市值为73.46亿元。公司于近日披露《关于“九强转债”恢复转股的提示性公告》。公告显示,因实施2025年年度权益分派,“九强转债”自2026年5月21日至权益分派股权登记日暂停转股;根据相关规定,“九强转债”将于股权登记日后的第一个交易日,即2026年5月29日起恢复转股。债券代码为123150,债券简称为九强转债。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0077","300406","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638368960","title":"九强生物(300406)披露可转债转股价格调整公告,5月27日股价下跌1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638368960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638368960?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:35","pubTimestamp":1779892518,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘,九强生物报收于12.51元,较前一交易日下跌1.88%,最新总市值为73.35亿元。该股当日开盘12.75元,最高12.8元,最低12.3元,成交额达5559.66万元,换手率为1.05%。本次转股价格调整不涉及送股或资本公积金转增股本等情况,仅因派送现金股利导致。调整后的转股价格自2026年5月29日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700046255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0046","BK0077","300406","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638716538","title":"九强生物:公司2025年年度权益分派股权登记日为","url":"https://stock-news.laohu8.com/highlight/detail?id=2638716538","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638716538?lang=zh_cn&edition=full","pubTime":"2026-05-25 15:18","pubTimestamp":1779693505,"startTime":"0","endTime":"0","summary":"证券之星消息,九强生物(300406)05月25日在投资者关系平台上答复投资者关心的问题。投资者提问:你好这都五月底了分红啥时候落实到位九强生物回复:您好,公司2025年年度权益分派股权登记日为:2026年5月28日,除权除息日为:2026年5月29日。具体内容详见公司披露于巨潮资讯网(http://www.cninfo.com.cn)的《2025年年度权益分派实施公告》(公告编号:2026-052)。以上内容为证券之星据公开信息整理,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500015081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0012","BK0028","BK0077","300406","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637820566","title":"股市必读:九强生物(300406)5月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2637820566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637820566?lang=zh_cn&edition=full","pubTime":"2026-05-21 03:24","pubTimestamp":1779305051,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,九强生物报收于12.83元,下跌1.08%,换手率0.64%,成交量2.73万手,成交额3508.05万元。董秘最新回复投资者: 公司在 2025 年 12 月 9 号公告中国医药投资要承让邹左军、刘希、孙小林合计5%的股份,请问目前该事项交接完毕了吗?请具体回答,不要模棱两可董秘: 您好,相关进展请您关注公司发布的公告内容,感谢您对公司的关注。交易信息汇总资金流向5月20日主力资金净流出298.67万元;游资资金净流出93.63万元;散户资金净流入392.29万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100004342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406","BK0028","BK0239","BK0046","BK0012","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636432088","title":"九强生物(300406)披露权益分派期间“九强转债”暂停转股公告,5月20日股价下跌1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636432088","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636432088?lang=zh_cn&edition=full","pubTime":"2026-05-20 18:09","pubTimestamp":1779271758,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘,九强生物报收于12.83元,较前一交易日下跌1.08%,最新总市值为75.22亿元。该股当日开盘12.92元,最高12.98元,最低12.78元,成交额达3508.05万元,换手率为0.64%。近日,九强生物发布《关于实施权益分派期间“九强转债”暂停转股的提示性公告》。公告显示,公司因实施2025年年度权益分派,根据相关规定,自2026年5月21日起至权益分派股权登记日止,可转换公司债券“九强转债”暂停转股,预计于股权登记日后的第一个交易日恢复转股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000034971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0012","BK0239","300406","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636951832","title":"九强生物(300406)披露2025年年度股东会决议公告,5月19日股价上涨0.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636951832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636951832?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:50","pubTimestamp":1779184247,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘,九强生物报收于12.97元,较前一交易日上涨0.46%,最新总市值为76.04亿元。该股当日开盘12.9元,最高13.11元,最低12.89元,成交额达4229.54万元,换手率为0.77%。九强生物于近日披露《2025年年度股东会决议公告》。公告显示,公司于2026年5月18日召开2025年年度股东会,会议由董事会召集,董事长邹左军主持,采用现场与网络投票结合方式召开。出席会议股东共133人,代表股份328,155,205股,占公司有表决权股份总数的56.3101%。其中两项议案为特别决议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900034165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300406","BK0046","BK0012","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636019669","title":"股市必读:九强生物(300406)5月15日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2636019669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636019669?lang=zh_cn&edition=full","pubTime":"2026-05-18 05:08","pubTimestamp":1779052097,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,九强生物报收于13.06元,上涨0.38%,换手率1.2%,成交量5.07万手,成交额6627.62万元。公司战略重点由“试剂龙头”向“全产业链病理生态商”升级,拓展至分子病理、伴随诊断与AI辅助诊断领域,强化自研抗体与设备国产化,并推动全自动染色仪在欧美市场装机。数智化病理投资逻辑基于临床医生短缺、政策支持与数据积累,相关AI项目已入围“揭榜挂帅”,研发有序推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800002079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0012","BK0046","300406","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633884311","title":"九强生物最新公告:取得三项医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2633884311","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633884311?lang=zh_cn&edition=full","pubTime":"2026-05-06 17:13","pubTimestamp":1778058796,"startTime":"0","endTime":"0","summary":"九强生物(300406.SZ)公告称,公司近日收到北京市药品监督管理局颁发的《医疗器械注册证》,包括α1-酸性糖蛋白测定试剂盒、免疫球蛋白E测定试剂盒及不饱和铁结合力测定试剂盒。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600026386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","300406","BK1574","09997","09996","BK0012","BK1100","BK0028","BK0046","BK1583","BK0239","BK0077","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633492660","title":"股市必读:4月30日九强生物现874.37万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2633492660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633492660?lang=zh_cn&edition=full","pubTime":"2026-05-06 04:06","pubTimestamp":1778011575,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,九强生物报收于12.7元,上涨2.58%,换手率2.15%,成交量9.13万手,成交额1.15亿元。当日关注点来自交易信息汇总:4月30日主力资金净流入920.43万元,占总成交额7.99%。来自交易信息汇总:当日发生874.37万元大宗交易。大宗交易4月30日九强生物现874.37万元大宗交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0077","BK0028","300406","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631757351","title":"股市必读:4月29日九强生物现1010.21万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2631757351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631757351?lang=zh_cn&edition=full","pubTime":"2026-04-30 07:23","pubTimestamp":1777504989,"startTime":"0","endTime":"0","summary":"截至2026年4月29日收盘,九强生物报收于12.38元,上涨0.57%,换手率1.46%,成交量6.21万手,成交额7725.01万元。当日关注点来自交易信息汇总:4月29日主力资金净流入104.76万元,呈现主动吸筹迹象。来自交易信息汇总:同日发生1010.21万元大宗交易,引发市场关注。大宗交易4月29日九强生物现1010.21万元大宗交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000025421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0012","BK0077","BK0239","300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630370583","title":"4月28日九强生物发生1笔大宗交易 成交金额1600.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630370583","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630370583?lang=zh_cn&edition=full","pubTime":"2026-04-28 18:15","pubTimestamp":1777371305,"startTime":"0","endTime":"0","summary":"证券之星消息,4月28日九强生物发生大宗交易,交易数据如下:大宗交易成交价格12.31元,成交130万股,成交金额1600.3万元,买方营业部为广发证券股份有限公司珠海九洲大道证券营业部,卖方营业部为广发证券股份有限公司珠海九洲大道证券营业部。近三个月该股共发生3笔大宗交易,合计成交2.15万手,折价成交1笔。截至2026年4月28日收盘,九强生物报收于12.31元,下跌2.92%,换手率2.75%,成交量11.66万手,成交额1.45亿元。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/28/20260428188732.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/28/20260428188732.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260428/32184493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0077","BK0012","BK0046","300406","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630468433","title":"九强生物(300406)2026年一季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2630468433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630468433?lang=zh_cn&edition=full","pubTime":"2026-04-28 06:53","pubTimestamp":1777330436,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期九强生物发布2026年一季报。截至本报告期末,公司营业总收入3.35亿元,同比上升4.69%,归母净利润1.06亿元,同比上升26.84%。本报告期九强生物盈利能力上升,毛利率同比增幅1.36%,净利率同比增幅20.71%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800022619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630381046","title":"九强生物(300406)3月31日股东户数2.12万户,较上期增加18.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630381046","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630381046?lang=zh_cn&edition=full","pubTime":"2026-04-26 17:13","pubTimestamp":1777194816,"startTime":"0","endTime":"0","summary":"证券之星消息,近日九强生物披露,截至2026年3月31日公司股东户数为2.12万户,较12月31日增加3242.0户,增幅为18.01%。户均持股数量由上期的3.26万股减少至2.76万股,户均持股市值为32.65万元。在医疗器械行业个股中,九强生物股东户数低于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.19万户。根据统计,九强生物2025年12月31日至2026年3月31日,主力资金净流出2.71亿元,游资资金净流入1.35亿元,散户资金净流入1.36亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600011209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300406","BK0012","BK0077","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630147381","title":"图解九强生物年报:第四季度单季净利润同比下降150.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630147381","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630147381?lang=zh_cn&edition=full","pubTime":"2026-04-26 16:48","pubTimestamp":1777193325,"startTime":"0","endTime":"0","summary":"证券之星消息,九强生物2025年年报显示,当年度公司主营收入13.56亿元,同比下降18.29%;归母净利润1.9亿元,同比下降64.73%;扣非净利润1.86亿元,同比下降64.64%;其中2025年第四季度,公司单季度主营收入3.44亿元,同比下降18.44%;单季度归母净利润-8258.66万元,同比下降150.08%;单季度扣非净利润-8411.43万元,同比下降154.26%;负债率25.13%,投资收益1213.56万元,财务费用4071.8万元,毛利率79.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600010285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629811037","title":"4月24日九强生物现500.76万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2629811037","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629811037?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:22","pubTimestamp":1777022535,"startTime":"0","endTime":"0","summary":"证券之星消息,4月24日九强生物发生大宗交易,交易数据如下:大宗交易成交价格11.7元,相对当日收盘价折价0.26%,成交42.8万股,成交金额500.76万元,买方营业部为广发证券股份有限公司珠海九洲大道证券营业部,卖方营业部为广发证券股份有限公司珠海九洲大道证券营业部。近三个月该股共发生1笔大宗交易,合计成交4280.0手,折价成交1笔。截至2026年4月24日收盘,九强生物报收于11.73元,下跌0.09%,换手率0.86%,成交量3.64万手,成交额4263.85万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400051903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0012","BK0239","300406","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627438939","title":"九强生物(300406.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2627438939","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627438939?lang=zh_cn&edition=full","pubTime":"2026-04-13 15:56","pubTimestamp":1776067001,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九强生物(300406.SZ)公告,公司全资子公司福州迈新生物技术开发有限公司于近日收到国家药品监督管理局颁发的《医疗器械注册证》,产品名称为:雌激素受体抗体试剂(免疫组织化学法)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427693.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","300406","BK0028","BK1583","BK0239","09997","09996","BK0046","BK0077","BK1100","BK1574","BK0012","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624654337","title":"九强生物(300406)披露获得2项发明专利证书公告,4月3日股价下跌3.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624654337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624654337?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:40","pubTimestamp":1775212827,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,九强生物报收于11.78元,较前一交易日下跌3.05%,最新总市值为69.07亿元。该股当日开盘12.1元,最高12.16元,最低11.74元,成交额达3856.16万元,换手率为0.77%。公告显示,公司近期获得2项发明专利证书,分别为丙戊酸检测试剂盒和样本系统。丙戊酸检测试剂盒采用新型丙戊酸衍生物及马来酰亚胺-巯基偶联方法,实现酶与衍生物1:1偶联,降低批间差,具备简便、快捷、低成本特点,适配多种主流自动化设备。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300406","BK0046","BK0239","BK0012","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623719309","title":"九强生物(300406.SZ)子公司取得多项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2623719309","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623719309?lang=zh_cn&edition=full","pubTime":"2026-03-31 15:57","pubTimestamp":1774943861,"startTime":"0","endTime":"0","summary":"智通财经APP讯,九强生物(300406.SZ)公告,公司全资子公司福州迈新生物技术开发有限公司于近日收到国家药品监督管理局颁发的《医疗器械注册证》,产品名称为:HER2抗体试剂(免疫组织化学法)、孕激素受体抗体试剂(免疫组织化学法)、CD20抗体试剂(免疫组织化学法)。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0028","BK0046","09997","BK1574","BK0012","BK1100","BK1222","09996","BK0077","BK0239","BK1583","159883","300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622557869","title":"九强生物(300406)披露获得2项发明专利证书公告,3月26日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622557869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622557869?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:31","pubTimestamp":1774535475,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘,九强生物报收于11.55元,较前一交易日下跌1.62%,最新总市值为67.72亿元。该股当日开盘11.72元,最高11.82元,最低11.49元,成交额达2964.68万元,换手率为0.6%。九强生物于近日披露《关于公司获得发明专利证书的公告》。公告显示,公司近期获得2项发明专利证书,分别为“酶标记物的制备方法”和“他克莫司检测试剂盒”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600044622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0046","BK0077","BK0239","BK0028","300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620786991","title":"3月20日九强生物创60日新低,招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2620786991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620786991?lang=zh_cn&edition=full","pubTime":"2026-03-20 16:25","pubTimestamp":1773995146,"startTime":"0","endTime":"0","summary":"证券之星消息,3月20日九强生物创60日新低,收盘报12.02元,当日跌1.72%,换手率0.87%,成交量3.68万手,成交额4462.02万元。重仓九强生物的公募基金请见下表:该股最近90天内共有1家机构给出评级,买入评级1家。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。该公募基金现任基金经理为李佳存。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000027791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0077","300406","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780164345203,"stockEarnings":[{"period":"1week","weight":-0.0326},{"period":"1month","weight":0.005},{"period":"3month","weight":-0.0525},{"period":"6month","weight":-0.0667},{"period":"1year","weight":-0.0467},{"period":"ytd","weight":-0.0481}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0095},{"period":"3month","weight":-0.0227},{"period":"6month","weight":0.0463},{"period":"1year","weight":0.2096},{"period":"ytd","weight":0.0251}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京九强生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"21242人(较上一季度增加18.01%)","perCapita":"19975股","listingDate":"2014-10-30","address":"北京市海淀区花园东路15号旷怡大厦5层","registeredCapital":"58630万元","survey":" 北京九强生物技术股份有限公司的主营业务是体外诊断试剂及体外诊断仪器的生产及销售。公司的主要产品是病理诊断系统、生化诊断系统、血凝诊断系统、发光诊断系统、血型诊断系统、POCT诊断系统、液体活检系统。2025年1月14日,公司荣获“军事科学技术进步一等奖”,2025年12月6日,公司凭借高质量的信息披露水平、高效的沟通方式、优异的公共关系管理和投资者关系管理能力,荣获“金信披奖”。","listedPrice":14.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"九强生物,300406,九强生物股票,九强生物股票老虎,九强生物股票老虎国际,九强生物行情,九强生物股票行情,九强生物股价,九强生物股市,九强生物股票价格,九强生物股票交易,九强生物股票购买,九强生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"九强生物(300406)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供九强生物(300406)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}